As high-tech care decisions led to value clashes in hospital corridors, ethics committees developed to respond to diverse viewpoints, families’ concerns, and clinicians’ moral distress. They now exist in almost all US health care organizations.
AMA J Ethics. 2016; 18(5):546-553. doi:
10.1001/journalofethics.2016.18.5.mhst1-1605.
Hanni Stoklosa, MD, MPH, Marti MacGibbon, CADC-II, ACRPS, and Joseph Stoklosa, MD
Clinicians diagnosing and treating potentially trafficked patients with co-occurring addiction and mental illness should guard against expressing negative biases.
AMA J Ethics. 2017; 19(1):23-24. doi:
10.1001/journalofethics.2017.19.1.ecas3-1701.
Carrie A. Bohnert, MPA, Aaron W. Calhoun, MD, and Olivia F. Mittel, MD, MS
Research and training are needed so that physicians are able to identify human trafficking victims and refer them to appropriate trauma-informed treatment.
AMA J Ethics. 2017; 19(1):35-42. doi:
10.1001/journalofethics.2017.19.1.ecas4-1701.
Physicians should provide women considering abortion after Down syndrome screening with unbiased information and not attempt to influence their decision.
AMA J Ethics. 2016; 18(4):359-364. doi:
10.1001/journalofethics.2016.18.4.ecas1-1604.
Professor Katie Watson joins Ethics Talk to discuss what clinicians need to know about changes to the post-June 2022 legal, ethical, and clinical landscape of abortion care in the US.
Principles of respect for autonomy, beneficence, and nonmaleficence guide trauma-informed care. Care ethics should also support this framework for responding to the health needs of trafficked patients.
AMA J Ethics. 2017; 19(1):80-90. doi:
10.1001/journalofethics.2017.19.1.msoc2-1701.
S. Michelle Ogunwole, MD, PhD and Francheska D. Starks, PhD
Testimonial injustice is an expression of racism that uses identity to undermine individuals’ credibility as authoritative “knowers” of their own bodies, selves, and experiences.
AMA J Ethics. 2024; 26(1):E72-83. doi:
10.1001/amajethics.2024.72.
The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions.